Forian Inc.
$2.16
▲
0.96%
2026-04-21 06:54:02
forian.com
NCM: FORA
Explore Forian Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$67.1 M
Current Price
$2.16
52W High / Low
$2.71 / $1.64
Stock P/E
—
Book Value
$0.96
Dividend Yield
—
ROCE
-8.29%
ROE
-9.61%
Face Value
—
EPS
$-0.09
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
50
Beta
0.99
Debt / Equity
0.04
Current Ratio
2.96
Quick Ratio
2.97
Forward P/E
23.78
Price / Sales
2.21
Enterprise Value
$35.25 M
EV / EBITDA
-9.93
EV / Revenue
1.17
Rating
None
Target Price
$2.1
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Schrödinger, Inc. | $12.8 | — | $944.96 M | — | -31.08% | -26.29% | $27.63 / $10.95 | $4.94 |
| 2. | VSee Health, Inc. | $0.24 | — | $11.87 M | — | -476.79% | -5.42% | $2.52 / $0.19 | $-0.33 |
| 3. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
| 4. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 5. | Claritev Corporation | $22.45 | — | $349.35 M | — | 0.97% | 632.6% | $74.07 / $12.04 | $-10.51 |
| 6. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 7. | Talkspace, Inc. | $5.18 | 111.06 | $865.45 M | — | 2.68% | 6.65% | $5.2 / $2.22 | $0.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.96 M | 7.76 M | 7.48 M | 7.06 M | 5.81 M | — |
| Operating Profit | -0.83 M | -0.3 M | 0.05 M | -1.39 M | -1.17 M | — |
| Net Profit | -1.82 M | -0.15 M | 0.22 M | -1.13 M | 0.2 M | — |
| EPS in Rs | -0.06 | -0 | 0.01 | -0.04 | 0.01 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 30.26 M | 20.15 M | 21.22 M | 16.42 M |
| Operating Profit | -2.47 M | -5.56 M | -3.3 M | -13.54 M |
| Net Profit | -2.87 M | -3.77 M | 11.77 M | -25.97 M |
| EPS in Rs | -0.09 | -0.12 | 0.38 | -0.83 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 44.13 M | 47.17 M | 60.41 M | 46.26 M |
| Total Liabilities | 14.35 M | 17.12 M | 32.69 M | 33.84 M |
| Equity | 29.78 M | 30.05 M | 27.72 M | 12.42 M |
| Current Assets | 42.56 M | 44.46 M | 58.8 M | 26.92 M |
| Current Liabilities | 14.35 M | 16.6 M | 6.82 M | 8.35 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.89 M | 0.28 M | 0.73 M | -8.58 M |
| Investing CF | 12.94 M | 17.29 M | 7.12 M | -6.46 M |
| Financing CF | -7.52 M | -19.02 M | -4.6 M | -0.1 M |
| Free CF | 2.89 M | 0.28 M | 0.65 M | -8.63 M |
| Capex | — | — | -0.08 M | -0.05 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -5.01% | 29.23% | — | — |
| Earnings Growth % | -132.04% | 145.31% | — | — |
| Profit Margin % | -18.71% | 55.47% | -158.19% | — |
| Operating Margin % | -27.59% | -15.55% | -82.44% | — |
| Gross Margin % | 63.61% | 74.19% | 69.24% | — |
| EBITDA Margin % | -14.44% | 16.08% | -111.19% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.